Janssen’s Single-Shot COVID-19 Vaccine Gets Emergency Use Authorization
The FDA has granted Emergency Use Authorization to Janssen’s single-dose vaccine for active immunization to prevent COVID-19.
The FDA has granted Emergency Use Authorization to Janssen’s single-dose vaccine for active immunization to prevent COVID-19.
New drugs approved for anaphylaxis, primary biliary cholangitis, prurigo nodularis, and more.
The 2023-2024 formulation of the vaccine is no longer authorized for use.
DaylightRx is intended to provide cognitive behavioral therapy for patients aged 22 years and older with GAD.
CDC Advisory Committee issue vaccine guidelines for flu season; Smallpox vaccine gains expanded indication; Updated Novavax COVID-19 vaccine; Over-the-counter gel for erectile dysfunction; New inserter…
The PDUFA date refers to the deadline set by the US Food and Drug Administration for reviewing drug applications.
The OTC gel is applied to the penis just before sex and has an onset of action of 10 minutes.
The 2023-2024 formulation of the vaccine is no longer authorized for use.
The update was supported by available information including variant susceptibility to Pemgarda and national variant frequencies.
The single-dose vials are available for purchase through LillyDirect with a valid prescription.
A review of recent medical-related criminal activity related to the unlawful dispensing and distribution of prescription medications.